BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

DualityBio, BioNTech Expand Partnership for Solid Tumor Antibody-Drug Conjugate

The agreement further builds upon the strategic collaboration the companies announced in April 2023. Under the terms of the agreements, DualityBio will re...

August 08, 2023 | News

Pfizer Malaysia Teams Up with Sunway Medical Centre and Pharmacy to Promote Early Atrial Fibrillation Detection

In the initial phase of the AF360 campaign, Pfizer, via its distributor, has provided registered medical portable ECG screening devices to Sunway Multicare...

August 08, 2023 | News

Proteintech Accelerates Growth with Expansions in the US and China

Proteintech, the benchmark in antibodies and life science solutions, recently expanded at its US headquarters in Rosemont, IL, opened up a new office in Sh...

August 07, 2023 | News

Certara Teams Up with Korea Institute of Toxicology for FDA-Ready SEND Dataset

Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certar...

August 04, 2023 | News

JinMed's Nanobathing Products Earn Patents, Secure Procurement Deal with Shanghai Zhongjin HongKang Medical Technology

Currently, the Company's nanobathing products have been granted an invention patent and four utility model patents. Among them, one medical nanobathing car...

August 04, 2023 | News

MANA Develops Novel "Drycell" Microdroplets to Make Handling Single Cell Easier

To analyze individual cells, the desired number of cells must be isolated spatially. This often requires extensive training and use of expensive laboratory...

August 04, 2023 | News

Doer Biologics Initiates Phase I MAD Trial of DR10624, Receives NMPA IND Approval

The Phase I MAD study is a randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics ...

August 02, 2023 | News

Everest Medicines Completes Patient Enrollment for Nefecon® China Study

The cOLE study offers an additional 9 months of treatment with Nefecon® to all qualifying patients who have completed the NefIgArd study and will evalu...

August 01, 2023 | News

Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia’s Access to Vaccines

Zuellig Pharma today announced that it has entered into an agreement with global biopharma company, GSK, to help set up its first vaccine distribution ...

August 01, 2023 | News

Daewoong Pharmaceutical Seeks Approval for Fexuprazan in China's Anti-Ulcer Drug Market

Daewoong Pharmaceutical's domestically produced drug no. 34 Fexuprazan, a newly developed one for the treatment of gastroesophageal reflux disease (GERD), ...

July 31, 2023 | News

AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine

AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research...

July 28, 2023 | News

HaemaLogiX, Peter MacCallum Cancer Centre Announce Myeloma CAR-T Trial Agreement

HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's ...

July 26, 2023 | News

China's Mabwell Announces NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND

B7-H3 is a member of the B7 ligand family and is overexpressed in most cancer types but expressed at a low level in normal tissues. In malignant tissues, B...

July 24, 2023 | News

SCG Cell Therapy Launches Cutting-edge Facility in Singapore for Cell Therapy Manufacturing & R&D

SCG Cell Therapy celebrates the opening of its new Cell Therapy Manufacturing Facility and R&D Centre, launching a new first-of-its-kind automatic ce...

July 20, 2023 | News

Stay Connected